This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 Oct 5;377(14):1313-1315.

doi: 10.1056/NEJMp1711886. Epub 2017 Sep 13.

Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy

Lisa Rosenbaum¹

Affiliations

PMID: 28902570
DOI: 10.1056/NEJMp1711886

Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy

Lisa Rosenbaum. N Engl J Med. 2017.

. 2017 Oct 5;377(14):1313-1315.

doi: 10.1056/NEJMp1711886. Epub 2017 Sep 13.

Author

Lisa Rosenbaum¹

Affiliation

¹ Dr. Rosenbaum is a national correspondent for the Journal.

PMID: 28902570
DOI: 10.1056/NEJMp1711886

No abstract available

PubMed Disclaimer

Similar articles

CAR T-cell therapy effective in B acute lymphoblastic leukaemia.
Wang M. Wang M. Lancet Oncol. 2017 Jun;18(6):e314. doi: 10.1016/S1470-2045(17)30364-9. Epub 2017 May 18. Lancet Oncol. 2017. PMID: 28528746 No abstract available.
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.
Cai B, Guo M, Wang Y, Zhang Y, Yang J, Guo Y, Dai H, Yu C, Sun Q, Qiao J, Hu K, Zuo H, Dong Z, Zhang Z, Feng M, Li B, Sun Y, Liu T, Liu Z, Wang Y, Huang Y, Yao B, Han W, Ai H. Cai B, et al. J Hematol Oncol. 2016 Nov 25;9(1):131. doi: 10.1186/s13045-016-0357-z. J Hematol Oncol. 2016. PMID: 27887660 Free PMC article. Clinical Trial.
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.
Zhang Y, Zhang W, Dai H, Wang Y, Shi F, Wang C, Guo Y, Liu Y, Chen M, Feng K, Zhang Y, Liu C, Yang Q, Li S, Han W. Zhang Y, et al. Sci China Life Sci. 2016 Apr;59(4):379-85. doi: 10.1007/s11427-016-5035-4. Epub 2016 Mar 24. Sci China Life Sci. 2016. PMID: 27009300
The what, when and how of CAR T cell therapy for ALL.
Frey N. Frey N. Best Pract Res Clin Haematol. 2017 Sep;30(3):275-281. doi: 10.1016/j.beha.2017.07.009. Epub 2017 Aug 3. Best Pract Res Clin Haematol. 2017. PMID: 29050700 Review.
CAR T cells for infection, autoimmunity and allotransplantation.
Maldini CR, Ellis GI, Riley JL. Maldini CR, et al. Nat Rev Immunol. 2018 Oct;18(10):605-616. doi: 10.1038/s41577-018-0042-2. Nat Rev Immunol. 2018. PMID: 30046149 Free PMC article. Review.

See all similar articles

Cited by

Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.
Fereydouni M, Motaghed M, Ahani E, Kafri T, Dellinger K, Metcalfe DD, Kepley CL. Fereydouni M, et al. Front Oncol. 2022 Mar 31;12:830199. doi: 10.3389/fonc.2022.830199. eCollection 2022. Front Oncol. 2022. PMID: 35433433 Free PMC article. Review.
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review.
Satapathy BP, Sheoran P, Yadav R, Chettri D, Sonowal D, Dash CP, Dhaka P, Uttam V, Yadav R, Jain M, Jain A. Satapathy BP, et al. Front Immunol. 2024 May 10;15:1389971. doi: 10.3389/fimmu.2024.1389971. eCollection 2024. Front Immunol. 2024. PMID: 38799440 Free PMC article.
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities.
Jones XM, Bottini N, Boin F, Marbán E. Jones XM, et al. J Scleroderma Relat Disord. 2025 Jan 20:23971983241313096. doi: 10.1177/23971983241313096. Online ahead of print. J Scleroderma Relat Disord. 2025. PMID: 39845449 Free PMC article. Review.
Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies.
Cheng J, Zhao L, Zhang Y, Qin Y, Guan Y, Zhang T, Liu C, Zhou J. Cheng J, et al. Front Oncol. 2019 Nov 21;9:1237. doi: 10.3389/fonc.2019.01237. eCollection 2019. Front Oncol. 2019. PMID: 31824840 Free PMC article. Review.
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances.
Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, Cherif H, Uddin S, Steinhoff M, Marincola FM, Dermime S. Maalej KM, et al. Mol Cancer. 2023 Jan 30;22(1):20. doi: 10.1186/s12943-023-01723-z. Mol Cancer. 2023. PMID: 36717905 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations